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Background: In HIV-1-infected human monocyte-derived macrophages (MDMs), virus particles assemble primarily
on intracellularly sequestered plasma membrane domains termed intracellular plasma membrane-connected
compartments (IPMCs). Despite their clear role in virus formation, little is known of the organization, composition,
dynamics or function of these compartments.
Results: We have used amphipathic membrane dyes to reveal the complex three-dimensional structure of IPMCs in
whole MDMs and to visualize connections between IPMCs and the cell surface. The observation of similar IPMC
structures in both infected and uninfected cells indicates that these compartments are not induced by virus
infection, but are present constitutively in MDMs. By expressing a phospholipase Cδ pleckstrin homology domain
linked to green fluorescent protein, we demonstrate that IPMCs contain phosphatidylinositol 4,5-bisphosphate. Live
cell imaging of cells expressing this probe shows that IPMCs are dynamic, but relatively stable, sub-domains of the
plasma membrane. As recent electron microscopy studies indicated that portions of IPMCs are coated with β2
integrin-containing focal adhesion-like complexes linked to actin, we investigated whether the actin cytoskeleton is
required for the organization of IPMCs. In MDMs treated with the actin polymerization inhibitor latrunculin, the
normally compact IPMCs dispersed into smaller structures that remained connected to the plasma membrane.
Moreover, latrunculin enhanced the release of preformed, mature HIV-1 particles from infected MDMs.
Conclusions: IPMCs are constitutive features of MDMs that are continuous with the plasma membrane and are
used as unique sites for the assembly of new virions following infection by HIV-1. A functionally intact actin
cytoskeleton is required to maintain the organization of the IPMCs and, in HIV-1-infected cells, perturbation of the
actin cytoskeleton influences both the organization of the compartment and the release of sequestered virus.
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CD4+ T-cells and macrophages are the major targets for
HIV-1 infection in vivo [1]. Unlike T-cells, macrophages
can survive for long periods of time following infection,
potentially serving as reservoirs of infectious virus [2]
that may facilitate the spread of virus to other target cells
and to the brain [3-5]. Previous work has shown that in
monocyte-derived macrophages (MDMs) differentiated in
culture and infected with HIV-1, new virus particles
assemble on intracellular membranes variously suggested* Correspondence: m.marsh@ucl.ac.uk
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distribution, and reproduction in any mediumto be derived from the Golgi apparatus [6] or endosome-
associated compartments [7-9]. However, recent studies
have shown that HIV assembly in MDMs takes place on
membranes that are connected to the plasma membrane
[10-16]. In HIV-infected MDMs, these intracellular plasma
membrane-connected compartments (IPMCs) appear to
be the primary sites of virus assembly, as budding profiles,
immature and mature virus particles can be seen within
the IPMC structures, but are only rarely observed at the
cell surface [10,14,17]. Electron microscopy (EM) has
revealed IPMCs to be complex networks of membranes
comprising tubules and vacuoles that can be connected
to the cell surface via narrow channels [10,11,13-15].
Although the function of IPMCs in MDMs is currentlytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Mlcochova et al. BMC Biology 2013, 11:89 Page 2 of 15
http://www.biomedcentral.com/1741-7007/11/89unclear, their presence in uninfected cells [11,14,15] indi-
cates that they are not solely involved in virus replication
but are likely to have other function(s) in macrophages.
Although well described morphologically, mainly in fixed
samples, little is known about the formation, function
or dynamics of IPMCs. Here, we used the membrane
dyes FM 4–64 and CellMask to investigate IPMCs and to
further understand their links to the cell surface. In
addition, using a green fluorescent protein (GFP)-tagged
pleckstrin homology (PH) domain from phospholipase Cδ
(PH-GFP), a probe that binds specifically to the lipid phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2), we could label
IPMCs and monitor their behavior in living MDMs. One
characteristic feature of IPMCs is the presence of areas of
electron-dense coat material on the cytoplasmic side of
the limiting membrane, close to meshworks of cytoskeletal
filaments [11,14]. These coats are related to focal adhesion
plaques, containing the integrins αM/αX β2 (CD11b,c/
CD18), together with the focal adhesion proteins talin,
paxillin and vinculin that link to the actin cytoskeleton
[14]. We therefore also investigated the role of the actin
cytoskeleton in the organization of IPMCs and the release
of mature, IPMC-sequestered HIV-1.
Results
Imaging of IPMCs with lipophilic membrane dyes
For the most part, IPMCs have been studied with regard
to their role in HIV-1 replication in macrophages. However,
previous work has suggested that IPMCs are also present
in uninfected MDMs and can be identified by immuno-
staining for membrane proteins such as CD9, CD81 or
the hyaluronic acid receptor CD44 [11,14,15]. As IPMCs
are thought to be continuous with the plasma membrane,
we investigated the ability of lipophilic dyes added to the
cell media to label these compartments.
Because IPMCs in MDMs have been shown to develop
with time in cell culture [14], we used 14-day-old MDMs
for all of the studies described here. Uninfected MDMs
were incubated with FM 4-64FX, a formaldehyde/glutar-
aldehyde-fixable analog of FM 4–64, a lipophilic dye that
fluoresces intensely on binding to the outer leaflet of lipid
bilayers (Figure 1A-C). Labeling was carried out on ice
to prevent endocytosis, through which the dye might
access intracellular membranes by vesicular carriers [18].
Subsequently, the cells were fixed and imaged. This allowed
rapid and specific labeling of the cell surface plasma
membrane. In addition, FM 4–64 labeling was seen in
prominent intracellular structures reminiscent of CD9-,
CD81- or CD44-labeled IPMCs (Figure 1A-C). In three-
dimensional reconstructions of FM 4-64FX-labeled cells
from optical sections, the IPMCs appeared as clusters of
interconnected vacuoles with occasional direct contacts
to the cell surface (Figure 1A-C and Additional file 1).
Because the cells were stained on ice in the absence ofendocytosis, and we saw no labeled vesicles resembling
endocytic organelles (compare with Figure 2C), we assume
that these connections allowed the dye to access the
IPMCs. To confirm that IPMCs labeled with FM 4–64
correspond to the compartments where HIV assembles,
we expressed the HIV structural protein Gag linked to
GFP (Gag-GFP), which is also targeted to CD81- and
CD44-positive IPMCs in MDMs (AP-M, unpublished data),
and stained these cells with FM 4-64FX. In transfected
MDMs, both Gag-GFP and FM 4–64 co-localized in
IPMCs (Figure S1A in Additional file 2).
In an alternative approach, we used CellMask Plasma
Membrane Stain, a negatively charged amphipathic mol-
ecule reported to undergo only slow internalization, to label
MDMs. Cells were incubated with the dye for 5 minutes at
37°C or 30 minutes at 4°C, fixed and analyzed by confocal
microscopy. As with FM 4-64FX, CellMask labeled the cell
surface as well as surface-connected IPMCs (Figure 1D-F).
Because the labeling showed the same pattern at both
temperatures (Figure S1B in Additional file 2), we labeled
cells for 5 minutes at 37°C for all further experiments with
CellMask. The slow internalization of this dye also allowed
us to observe IPMCs in living cells by spinning disc
confocal microscopy for up to 20 minutes before uptake
of the dye into endosomes became apparent. This allowed
us to image whole cells and IPMCs in three dimensions
while avoiding possible changes associated with fixation
and without simultaneous labeling of endosomes and/or
lysosomes (Figure 1D-F and Additional file 3). Together
these studies indicated that IPMCs in uninfected MDMs
can contain several interconnected vacuole-like structures
with connections to the cell surface, though the numbers of
connections varied for individual cells. For example, in 11
different three-dimensional reconstructions of CellMask-
stained MDMs, three IPMCs had a single connection to
the cell surface, while eight had two or more. Similarly, in
five FM 4-64-labeled MDMs, four IPMCs showed two or
more connections to the cell surface.
We also used CellMask to label 14-day-old uninfected
MDMs and equivalent cells (from the same donor) that had
been infected with HIV-1 for 7 days (Figure 1G,H). Most
of the cells showed labeling of intracellular compartments,
although there was significant cell-to-cell variability in
the size and morphology of the IPMCs (several examples
are documented in Figure S1B in Additional file 2). To
determine whether HIV infection induces the de novo
formation of IPMCs, we inspected single optical sections
such as those shown in Figure 1G, H and counted the
numbers of cells with prominent CellMask-labeled IPMCs
(that is, structures >0.9 μm, where 0.9 μm was set as
the lower limit for analysis) in the uninfected and HIV-
infected MDMs. In this analysis, 28 ± 5.3% of the unin-
fected and 31 ± 2.4% of the cells in the infected MDM
cultures contained IPMCs (200 cells counted), indicating
Figure 1 Visualization of IPMCs in MDMs. (A-C) Uninfected MDMs were labeled with 5 μg/ml FM 4-64FX, fixed and analyzed by confocal microscopy.
(A) Shows a single optical section, (B) a three-dimensional reconstruction assembled from 131 optical z-slices (step size of 0.04 μm), and (C) a detail of the
IPMC shown in B. See also Additional file 1. (D-F) Live cell imaging of uninfected MDMs labeled with CellMask; (D) shows a single section, (E) a
three-dimensional reconstruction assembled from 165 optical z-slices (step size of 0.1 μm), and (F) a detail of the IPMC. See also Additional file 3. Cells were
imaged using an UltraVIEW Vox spinning disc confocal system (PerkinElmer, Cambridge, UK) fitted on a Nikon ECLIPSE Ti microscope equipped with a
temperature and CO2-controllable environment chamber. (G,H) Uninfected MDMs (G) or MDMs infected with HIV-1 for 7 days (H) were labeled with the
membrane-impermeable dye CellMask and fixed. The images show single confocal sections. Arrowheads mark CellMask-stained IPMCs. (I-K) Uninfected
MDMs were nucleofected with an expression plasmid encoding PH-GFP and 24 hours later were fixed and imaged by confocal microscopy; (I) shows a
single section, (J) a three-dimensional reconstruction assembled from 230 optical z-slices (step size of 0.04 μm), and (K) a detail of the IPMC. See also
Additional file 4. The confocal images were acquired with a Leica TCS SPE confocal microscope, 63× oil objective (NA 1.3) and Leica LAS Software, and
processed using Adobe Photoshop, ImageJ and Fiji. All experiments were repeated with cells from at least three different donors. All scale bars = 10 μm.
IPMC: intracellular plasma membrane-connected compartments; PH-GFP: Phospholipase Cδ pleckstrin homology domain linked to GFP.
Mlcochova et al. BMC Biology 2013, 11:89 Page 3 of 15
http://www.biomedcentral.com/1741-7007/11/89
Figure 2 Localization of PI(4,5)P2 and phosphatidylinositol 3-phosphate in MDMs. MDMs were nucleofected to express PH-GFP, to localize (A,B)
PI(4,5)P2 or (C) a double-FYVE domain construct fused to GFP (2xFYVE-GFP), a probe for phosphatidylinositol 3-phosphate. After 24 hours the cells were
fixed and co-stained for CD81 or CD44 as indicated. (D) Seven-day-old MDMs were infected with HIV-1BaL and after a further 7 days were nucleofected to
express PH-GFP, incubated for 24 hours, then fixed and stained for the viral matrix protein p17. Images show single confocal sections, and were acquired
with a Leica SPE confocal microscope as in Figure 1. All experiments were repeated on cells from at least three different donors. Scale bars = 10 μm.
PI(4,5)P2: Phosphatidylinositol 4,5-bisphosphate; PH-GFP: Phospholipase Cδ pleckstrin homology domain linked to GFP.
Mlcochova et al. BMC Biology 2013, 11:89 Page 4 of 15
http://www.biomedcentral.com/1741-7007/11/89that HIV infection does not itself induce the formation of
IPMCs. As CellMask staining does not survive detergent
extraction, co-staining for virus was not possible. However,
independent labeling of MDMs for the HIV-1 matrix pro-
tein (p17) showed that approximately 22 ± 5% of the cells
were producing mature virus (200 cells counted), with most
viral staining located in the IPMCs. Together, these studies
show that IPMCs, similar to the previously described HIV
assembly compartments, are present in uninfected as well
as HIV-1 infected cells, connected to the cell surface, and
exhibit high cell-to-cell morphological variability.
IPMCs contain PI(4,5)P2
The phosphoinositide PI(4,5)P2, which is located primarily
in the cytoplasmic leaflet of the plasma membrane [19],is essential for targeting of HIV-1 Gag to the plasma
membrane prior to virus assembly [20,21]. Because HIV
assembly in MDMs takes place in IPMCs, we asked whether
PI(4,5)P2 is also present in these compartments. Unin-
fected MDMs were nucleofected with an expression
construct encoding the PH domain of phospholipase
Cδ fused to GFP (PH-GFP), which specifically binds
PI(4,5)P2. After 24 hours, the cells were fixed and stained
for CD81 or CD44. PH-GFP was detected at the cell sur-
face plasma membrane and also in IPMCs (Figure 1I),
where it co-localized with CD81 and CD44 (Figure 2A,B).
As with the membrane-impermeable dyes, PH-GFP
outlined the membranes of IPMCs, revealing complex
interconnected membrane structures with larger, vacuole-
like components linked by fine membrane tubules or
Mlcochova et al. BMC Biology 2013, 11:89 Page 5 of 15
http://www.biomedcentral.com/1741-7007/11/89channels that also occasionally connected them to the cell
surface (Figure 1I-K and Additional file 4). Furthermore,
the compartments outlined by PH-GFP were morpho-
logically variable, even between cells from the same donor;
most of the MDMs contained one single complex IPMC
but others showed more dispersed smaller IPMCs (Figure
S1C in Additional file 2), and many of the IPMCs had
more than one connection to the cell surface. By contrast,
in MDMs nucleofected to express a double-FYVE domain
construct fused to GFP (2×FYVE-GFP), which binds
specifically and with high affinity to phosphatidylinositol
3-phosphate (a lipid associated primarily with early
endosomes and the intralumenal vesicles of multivesicular
endosomes [22]), vesicles were seen with a distribution that
was clearly distinct from the structures stained with PH-
GFP, CellMask or FM 4–64 dye and that did not overlap
with the CD81-labeled IPMCs (Figure 2C).
To confirm the presence of PI(4,5)P2 in the IPMCs,
we labeled MDMs with the mouse monoclonal anti-PI
(4,5)P2 antibody 2C11 [23,24] using two different labe-
ling protocols (see Methods). Labeled IPMCs were
rarely seen on saponin-permeabilized cells, but after
permeabilization with Triton X-100, most IPMCs were
strongly stained by the PI(4,5)P2-specific antibody
(Additional file 5).
We also infected 7-day-old MDMs with HIV-1 and 6
days later, nucleofected them with the PH-GFP expression
construct. After 24 hours the cells were fixed and labeled
for the viral matrix protein p17. In the infected cells
expressing PH-GFP, both PH-GFP and p17 clearly
co-localized in IPMCs (Figure 2D and Figure S1C in
Additional file 2). However, MDMs containing both
PH-GFP and p17 labeling were rare, suggesting that
HIV-infected cells may be more difficult to transfect or,
possibly, that the PH-GFP might compete with HIV-1Figure 3 Live cell imaging of IPMCs. MDMs were nucleofected to express
confocal system, as described in Figure 1 (see Additional files 6 and 7). Image
objective (NA 1.4) using Volocity 5.3.2 (Perkin Elmer) and the Perfect Focus Sy
software. The white arrowheads in A and B show connections to the cell surf
marked by the red boxes. All experiments were repeated on cells from at leasGag for PI(4,5)P2 binding, though this has not been
tested directly.
The presence of PI(4,5)P2 on IPMCs, together with our
previous data showing the plasma membrane markers
CD44 and CD81 as well as the endocytic clathrin adaptor
complex AP2 on IPMCs [14], further supports the notion
that IPMCs are intracellularly sequestered domains of the
plasma membrane present in uninfected and HIV-infected
MDMs.
Live cell imaging of IPMCs
Expression of PH-GFP allowed us to study the behavior
of IPMCs in living MDMs by spinning disc confocal
microscopy. All analyzed PH-GFP-labeled IPMCs appeared
stable during the recording periods (usually 1 hour;
Figure 3A,B; Additional files 6 and 7), though the struc-
tures were dynamic, and, in some cases, connections to
the cell surface were observed (Figure 3 arrowheads).
To investigate the dynamic behavior of IPMCs, we used
fluorescence recovery after photobleaching (FRAP) and
fluorescence loss in photobleaching (FLIP) techniques
on MDMs expressing PH-GFP (Figure 4). For the FRAP
experiments, the entire IPMC within a cell was photo-
bleached and the recovery of fluorescence was monitored.
Fluorescence recovered quickly in the bleached areas, with
a mean half time of recovery of 2.7 seconds (range 1.2
seconds to 3.4 seconds; 13 cells recorded) and mobile
fraction of 70% (Figure 4A). Similar recovery half times
and mobile fractions were observed in FRAP studies
when we compared the cell surface plasma membranes
and IPMC membranes (Figure 4C). For the FLIP experi-
ments, the cell surface membrane was repeatedly bleached
with 20 millisecond pulses of laser illumination and the
decay of the fluorescence signal of the corresponding
IPMC was measured by acquiring an image of the samplePH-GFP and imaged after 24 hours using an UltraVIEW Vox spinning disc
s were recorded at 6 frames/minute with a 60× Nikon oil immersion
stem, and analyzed with Volocity, Adobe Photoshop, ImageJ and Fiji
ace. The images A’, B’ at the right show enlargements of the areas
t three different donors. Scale bars = 20 μm.
Figure 4 FRAP and FLIP analysis of MDMs expressing PH-GFP. MDMs were nucleofected to express PH-GFP and FRAP or FLIP analysis was
performed 24 hours later using an UltraVIEW Vox spinning disc confocal system. Images were recorded at 6 frames/minute with a 100× Nikon oil
immersion objective (NA 1.4) with Volocity 5.3.2 (Perkin Elmer). (A) FRAP: The PH-GFP-labeled IPMC (white selection) was bleached with a 20
millisecond laser pulse (488-nm laser at 50% intensity), and recovery of fluorescence was measured for 20 seconds by collecting frames at
maximum speed. Data are shown in the graph on the right. (B) FLIP: The cell surface plasma membrane (white selection) was repeatedly
bleached with 10 × 20 millisecond pulses of the 488 nm laser at 50% intensity using the UltraVIEW PK device. After each bleaching pulse, the
fluorescence was monitored at various areas of interest for 10 seconds at maximum speed. The bleach and recovery cycle was repeated 10 times.
The graph on the right shows the levels of fluorescence at the cell surface plasma membrane (PM, the photobleached area) or at the IPMC,
compared to the plasma membrane of a different cell away from the bleached region (negative control). All experiments were repeated on cells
from at least two donors. (C) Comparison of FRAP at the cell surface over IPMC membranes. Selected 2 × 2 μm2 areas at the cell surface or over
IPMCs were photobleached, and FRAP was measured. The graph shows the average of 10 measurements in different cells from the same donor.
Scale bars = 10 μm.
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crease in the fluorescence signal in the IPMCs as the
cell surface plasma membrane was bleached (Figure 4B).
Similarly, in experiments where the IPMC was bleached
within the cells, we observed a loss in the cell surface
plasma membrane fluorescence intensity (data not shown).
Together, the FRAP and FLIP data support the notion that
IPMCs can exchange PH-GFP through lateral diffusion
or cytosol-membrane exchange or a combination of both.
These experiments show, for the first time, the behavior
of IPMCs in uninfected, living MDMs and demonstrate
that they are stable but dynamic structures.
The actin cytoskeleton maintains the integrity of the IPMC
Our recent EM analysis of HIV-infected MDMs re-
vealed a meshwork of actin filaments adjacent to β2-
integrin-containing electron-dense membrane coats onHIV-containing IPMCs [14]. Similar filament meshworks
can be seen in Figure 5A (arrows). We confirmed the
presence of actin near the IPMCs by staining with
Alexa Fluor 594-phalloidin and co-labeling for CD81
on uninfected MDMs (Figure 5B), or with anti-p17,
identifying mature virions, on HIV-infected cells
(Figure 5C).
To investigate whether actin plays a role in maintaining
the integrity and organization of the IPMCs, HIV-infected
MDMs were treated with the actin polymerization inhibitor
latrunculin. Immunofluorescence staining showed that, in
control cells, p17-containing mature HIV was located
in large IPMCs and associated with actin (Figures 5
and 6A,B). After 2 hours of latrunculin treatment, actin
was largely depolymerized and accumulated in the nuclei
(Additional file 8), as previously described for latrunculin-
treated mast cells [25]. At the same time, the staining
Figure 5 Association of actin with IPMCs. (A) HIV-infected MDMs were embedded in Epon, sectioned and analyzed by transmission EM, as
previously described [14]. HIV particles are seen in a complex IPMC. Some of the IPMC membranes are covered with a coat of electron-dense
focal adhesion proteins (arrowheads) and a layer of fine filaments (black arrows). L, lipid droplets; M, mitochondrion; the asterisk marks a budding
HIV particle. Epon EM was conducted on MDMs from two donors. Scale bar = 500 nm. (B) Uninfected MDMs were stained for CD81 and actin
(Alexa Fluor 594-conjugated phalloidin). (C) HIV-1-infected MDMs were stained for the matrix protein p17 and actin. The images show single
optical sections acquired with a Leica SPE confocal microscope as above. Scale bars = 10 μm.
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the cells (Figure 6A,B). A similar effect was observed
when actin was depolymerized by cytochalasin E or D
(Additional file 9). To quantify this effect, we counted the
numbers of MDMs with compact, dispersed, or mixed
(compact and dispersed) IPMCs in control MDMs or
in cells treated with latrunculin, cytochalasin E or cyto-
chalasin D. Perturbation of the actin cytoskeleton led to a
statistically significant decrease in the number of cells with
compact IPMCs (P <0.01) and a concomitant increase
in the number of cells with dispersed compartments
(Figure S4B,C in Additional file 9). Immuno-EM analysis
of latrunculin-treated, HIV-infected MDMs demonstrated
that HIV and immature budding particles were still found inintracellular compartments, although the IPMCs appeared
more dispersed throughout the cells (Additional file 10).
To study the structure of the IPMCs in latrunculin–
treated cells more directly, infected MDMs were labeled
with the CellMask dye. This again revealed that latrunculin
treatment caused the dispersal of the usually compact
IPMCs into smaller structures (Additional file 11). CellMask
labeling demonstrated that these smaller, more scattered
IPMC structures were accessible from the cell surface; in-
deed in three-dimensional reconstructions, some connec-
tions to the cell surface were apparent (Additional file 11).
Likewise, when MDMs were transfected with PH-GFP for
24 hours and then treated with latrunculin, the labeled
compact IPMC dispersed to a network of membranes
Figure 6 Actin assembly is required for the integrity of the IPMCs. (A-C) HIV-infected MDMs were treated with medium containing dimethyl
sulfoxide (control) or 2 μM latrunculin A for 2 hours. (A) Cells were stained with an anti-p17 antibody that only recognizes mature virus particles
and Alexa Fluor 594-conjugated phalloidin to label actin. (B) Enlargements of the marked areas in panel A. The images show single optical
sections acquired with a Leica SPE confocal microscope as above. (C) HIV-infected macrophages were labeled with CellMask for 5 minutes at
37°C, fixed and imaged with an UltraVIEW Vox spinning disc confocal system as described in Figure 3 (see Additional file 11). (D,E) MDMs were
nucleofected to express Gag-GFP and imaged after 24 hours using an UltraVIEW Vox spinning disc confocal system as described above (see
Additional files 14 and 15). Images were recorded at 6 frames/minute with a 60× Nikon oil immersion objective (NA 1.4) using Volocity 5.3.2
(Perkin Elmer) and analyzed with Volocity, Adobe Photoshop, ImageJ and Fiji software. The cell periphery is indicated with the dashed white line.
The white arrowheads in (E) show Gag-GFP in thin channels between the IPMC and the cell surface. The image E’ shows an enlargement of the
area marked by the red box. (F) MDMs, co-transfected to express Gag-GFP and LifeAct-Ruby for 24 hours, were treated with 2 μM latrunculin A
and imaged for 1.5 hours with the spinning disc confocal system (see also Additional file 16). All experiments were repeated with cells from at
least two different donors. All scale bars = 10 μm.
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files 12 and 13). These observations suggest that actin
depolymerization causes the usually tightly packed IPMC
membranes to open up, giving rise to a more reticular
network of membranes throughout the cell.
We also studied the behavior of IPMCs in the presence
of HIV-1 Gag-GFP and the effect of disrupting the actin
cytoskeleton by live cell imaging. MDMs were nucleofected
to express Gag-GFP and monitored by spinning disc con-
focal microscopy. Accumulations of Gag-GFP, presumablyvirus-like particles and/or Gag-GFP protein clusters,
were seen in intracellular structures resembling the
IPMCs that appeared stable for over one hour without
any significant rearrangements (Figure 6D and Additional
file 14). Occasionally Gag-GFP was also seen in thin chan-
nels emanating from the IPMCs (Figure 6E and Additional
file 15), perhaps equivalent to the virion-channeling
tube-like structures described by Bennett et al. [10].
In experiments where MDMs were nucleofected to
express Gag-GFP together with LifeAct-Ruby to label
Figure 7 Perturbation of actin polymerization enhances HIV-1 release from IPMC. (A) MDMs (4×105) were infected with HIV-1BaL for 7 days.
Cells were washed in phosphate-buffered saline, new medium was added and virus released into the culture supernatant was collected at the
indicated times, concentrated by centrifugation through a sucrose cushion and subjected to western blotting for HIV-1 Gag proteins. (B) MDMs were
infected with HIV-1BaL for 7 days, washed and treated with DMSO (control) or 2 μM latrunculin A for 2 hours. Right hand panels: HEK293T cells were
transfected with the HIV-1 molecular clone NL4.3-R3A, incubated for 48 hours and treated with DMSO (control) or 2 μM latrunculin A for 2 hours.
Viruses released during treatment were concentrated by centrifugation and viral proteins detected by western blotting. The blots were imaged with a
LAS4000 CCD camera and quantified using ImageQuant Software, as described in the Methods. Protein band intensities of treated samples were
normalized to the DMSO control. The western blots are representative examples of five independent experiments, while the graphs show the average
of five independent experiments. (C) MDMs infected for 7 days were treated simultaneously with the HIV-1 protease inhibitor amprenavir (PRI) and
latrunculin A for 2 hours. The plot on the right shows band intensities of viral proteins quantified using ImageQuant software. The western blot is
representative of four independent experiments and the plot shows the average of four independent experiments. Error bars represent standard
deviations. Significance is shown as the difference between latrunculin-treated and control cells *P <0.05; **P <0.01.
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latrunculin, the compact IPMCs initially seen in most cells
(Figure 6D,E and Figure 6F, 0 minute time point) became
more dispersed after 20 minutes of latrunculin treatment.
The Gag-GFP appeared more mobile in latrunculin-treatedcells (compare Additional files 14 and 15 with Additional
file 16), and, over 60 minutes, the IPMCs in latrunculin-
treated cells scattered into smaller structures; this coin-
cided with morphologically visible changes to the actin
cytoskeleton (Figure 6F and Additional file 16). We
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tain the morphological integrity of IPMCs.
Perturbation of actin enhances HIV-1 release from MDMs
Although HIV assembly in MDMs occurs primarily in
IPMCs [8,9,11,14,15], analysis of the media from HIV-
infected MDMs by immunoblotting indicates that HIV-1
can be released from IPMCs (Figure 7A). Given the changes
we observed in the appearance of IPMCs when the actin
cytoskeleton is disrupted, we asked whether disruption
of the actin cytoskeleton would affect HIV-1 release.
HIV-infected MDMs were treated with media containing
latrunculin or dimethyl sulfoxide (DMSO) for 2 hours,
and virus released into the medium during this time
was detected by immunoblotting. We observed increased
levels of capsid p24 and matrix p17 proteins in media
from latrunculin-treated MDMs compared to control cells
(Figure 7B). By contrast, HIV-transfected HEK293T cells,
which do not develop IPMCs and where virus assembly
takes place at the cell surface, did not show significant
changes in HIV release over this time period (Figure 7B).
Analysis of the media from HIV-infected MDMs by
p24-ELISA also revealed enhanced virus release from
MDMs treated with latrunculin, cytochalasin D or cytocha-
lasin E (Figure S4D in Additional file 9).
To confirm that latrunculin treatment affects virus
release rather than the rate of viral protein synthesis or
virus assembly, we inhibited virus maturation in MDMs
using the HIV-1 protease inhibitor amprenavir and sim-
ultaneously treated the cells with latrunculin. If disrup-
tion of the actin cytoskeleton stimulates viral protein
synthesis or the rate of assembly, the viruses released in
the presence of latrunculin and amprenavir should be
mainly immature (that is, contain mostly p55 and not
the cleaved p24 and p17 Gag products). By contrast, if
HIV assembly and Gag processing happen prior to the
latrunculin and amprenavir treatment, the released virus
would be mainly mature (that is, low in p55 and high in
p24 and p17). We detected the release of p24/p17-
containing mature virus particles from control cells
after treatment with the HIV-1 protease inhibitor, sug-
zgesting that this virus had accumulated in IPMCs be-
fore the inhibition of virus maturation. In latrunculin- and
amprenavir-treated cells, we again detected enhanced
virus release, and most of this was in the form of ma-
ture virus particles, suggesting that latrunculin induced
the release of preformed virus particles from IPMCs
(Figure 7C).
Together, these experiments demonstrate that perturb-
ation of the actin cytoskeleton causes the tightly packed
IPMC membranes to become more dispersed and may
lead to the opening of the narrow channels connecting
the compartments to the cell surface, and that this can
enhance the release of HIV from the compartments.Discussion
For some time, it has been known that in human MDMs,
HIV-1 buds into and accumulates in surface-connected
intracellular compartments, or IPMCs (also termed virus-
containing compartments or VCC [15,27]). Although their
origin, organization and function is poorly understood,
much of our current knowledge of these compartments
derives from EM studies, in which various techniques,
including serial sectioning, electron tomography or ion
abrasion scanning electron microscopy [10,11,13,15] have
indicated that IPMCs consist of complex intracellular
networks of membranes, with interconnected vacuole-like
and tubular components, and channel-like connections to
the cell surface. However, these morphological techniques
are limited to the analysis of small portions of the total
volume of fixed cells and do not provide information on
the dynamics of the compartments in real time. Here we
have used fluorescent membrane labels - FM 4–64,
CellMask and the PI(4,5)P2 probe PH-GFP, in combin-
ation with confocal z-series imaging, three-dimensional
volume reconstructions and live cell imaging - to study
the properties of IPMCs. In agreement with and extending
previous studies [10,11,13,15], we show that both unin-
fected and HIV-1-infected MDMs contain morphologic-
ally similar IPMCs that appear as dynamic networks of
vacuoles of various sizes, connected to each other and to
the cell surface by thinner tubules or closely apposed
membrane sheets. Furthermore, we show that the normal
morphology of IPMCs is dependent on the integrity of the
actin cytoskeleton and that disrupting this integrity can
stimulate the release of mature, IPMC-sequestered HIV-1.
EM analysis has previously shown individual HIV-
containing vacuoles and/or CD81-, CD9- or CD44-labeled
structures within MDMs, suggesting that a single cell may
contain several IPMC structures [10,11,13,15]. Our live
cell imaging studies, which avoid fixation-induced frag-
mentation of membrane compartments, indicate that these
vacuoles are in most cases sub-domains of single, larger
IPMCs. Moreover, although most MDMs contained a
single IPMC, three-dimensional reconstruction of complete
cells and IPMCs highlighted the complexity and extensive
cell-to-cell variability in the size and morphology of IPMCs.
The rapid labeling of IPMCs (within minutes), even at 4°C
when endocytosis is inhibited, and the visualization of at
least one, and frequently more, connections from IPMCs
to the cell surface provides additional evidence supporting
the notion that the compartment is continuous with the
cell surface and accessible to small molecule tracers, as
suggested by previous work [11,15,16]. Thus, the term
IPMC accurately reflects the fact that these compartments
are connected to the cell surface and that the IPMC mem-
brane can be regarded as a sub-domain of the plasma
membrane. Although accessible to small tracer molecules,
it has been suggested that IPMCs are not accessible to
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virus from recognition by neutralizing antibodies [13,28].
However, in our hands at least, IPMCs are accessible to
antibodies fed from the cell surface at 37°C [11] and
we find that many IPMCs can be accessed by high con-
centrations of antibodies or the fluid tracer horseradish
peroxidase when incubated for 1 hour at 4°C (AP-M,
unpublished data).
Significantly, many of the studies described here were
performed on uninfected MDMs, demonstrating that
IPMCs are not induced by HIV infection, although, as
previously shown, the compartment expands in size upon
HIV-1 infection [15]. IPMCs are therefore likely to have
some as yet unidentified function(s) in uninfected macro-
phages [11,15]. HIV appears to use pre-existing IPMCs for
assembly, suggesting that there is an advantage to the virus
to exploit these compartments or that key components
required for virus assembly are located within these plasma
membrane sub-domains. Currently, it is not clear how
HIV targets IPMCs, though the lipid PI(4,5)P2, which binds
directly to the HIV matrix basic domain and plays a key
role in Gag recruitment to the plasma membrane, is
likely to be involved [20,29]. We analyzed the distribution
of PI(4,5)P2 in MDMs, either using the PH-GFP probe or
immunostaining with a PI(4,5)P2-specific antibody [23,24].
PH-GFP labeled the cell surface as well as IPMCs, indi-
cating that PI(4,5)P2 is abundant in these locations. La-
beling of IPMCs with anti-PI(4,5)P2 antibody required
permeabilization with Triton X-100, and was poor after
saponin treatment, perhaps indicating the presence of
detergent-resistant membranes in IPMCs.
Given that the PH-GFP probe strongly stained IPMC
membranes, it could be used to follow the compartment
in live cell imaging studies. This allowed, for the first
time, studies of the behavior and dynamics of IPMCs in
uninfected macrophages. IPMCs labeled with PH-GFP
were essentially stable throughout the time of recording,
that is, for at least one hour. Similar observations were
made with MDMs transfected with Gag-GFP, where IPMCs
also appeared stable, though we could occasionally
observe changes in the subcellular distribution of Gag-GFP
in IPMCs and in IPMC-associated channels. Our studies
therefore complement previous analyses with Gag-GFP or
biarsenical-tetracysteine-tagged fluorescent Gag [13,30],
where accumulations in MDMs were also seen to be com-
paratively stable. FRAP and FLIP analyses of the PH-GFP
probe demonstrated that IPMC membranes are able to
rapidly exchange PH-GFP with surrounding membranes
and therefore they are dynamic structures. Interestingly,
we did not observe any kinetic differences in the behavior
of plasma membrane or IPMC-bound PH-GFP in our
experiments.
Because IPMCs are coated with actin filaments and, in
mature MDMs, the structure of the IPMCs is at least inpart stabilized via β2 integrin-containing focal adhesion-
like complexes linking to the actin cytoskeleton [14], we
investigated the role of actin in the organization of the
IPMCs. Inhibitors of actin polymerization (latrunculin,
cytochalasin D and cytochalasin E) caused the intracellular
accumulations of HIV particles to disperse into smaller
pockets of viruses, an effect similar to that seen after
depletion of β2 integrins in MDMs [14]. A similar effect
was previously described in dendritic cells [31] and may
explain the reduction in intracellular Gag accumulation
after cytochalasin D treatment of 7-day-old MDMs [12].
Staining with CellMask demonstrated that, although
dispersed, the IPMCs remained connected to the plasma
membrane in the drug-treated cells. In addition, when
MDMs were transfected with PH-GFP and treated with
latrunculin, the IPMCs appeared as a meshwork of
membranes with clear connections to the cell surface
(Additional file 12). We also showed that latrunculin
treatment did not inhibit virus assembly in MDMs, but
instead enhanced the release of preformed HIV-1 par-
ticles, presumably through the dispersed membrane
channels. Together these experiments suggest that an
intact actin cytoskeleton is required both to maintain
the structure of IPMCs and regulate the release of HIV
from MDMs. A recent study showed that microtubules
also affect the distribution of VCCs in MDMs, and sug-
gested that kinesin family-3A complexes may drive
IPMCs toward the plasma membrane and stimulate
virus release [27].Conclusion
We have demonstrated the complexity and plasticity of
IPMCs involved in HIV assembly in MDMs. We show
that these structures are resident compartments of
MDMs and that in uninfected and HIV-infected cells
the integrity of IPMCs is maintained and regulated
through the actin cytoskeleton. Although the function
of IPMCs in MDMs is unclear, similar intracellular
compartments have been seen in dendritic cells, where
they are involved in the formation of virological synapses
and in the trans-infection of T-cells by HIV and perhaps
other viruses [31-33]. In this context, remodeling of the
actin cytoskeleton may facilitate the recruitment of IPMCs
to the sites of cell-cell contact that form virological
synapses and may thus be involved in the spread of
virus to susceptible target cells.Methods
Reagents and antibodies
Tissue culture media and supplements were purchased
from Invitrogen (Paisley, UK), tissue culture plastic from
TPP (Trasadingen, Switzerland) and chemicals were from
Sigma-Aldrich (Dorset, UK), unless otherwise specified.
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(38:96K and EF7) and p17 (4C9) were obtained from the
National Institute for Biological Standards and Control
Center for AIDS Reagents (CFAR, South Mimms, UK).
Anti-CD81 (M38) was provided by F. Berditchevski
(University of Birmingham, UK); anti-PI(4,5)P2, (2C11;
IgM) was provided by G. Schiavo (Cancer Research UK,
London); anti-CD44 (MEM-85) was from Abcam Ltd.
(Cambridge, UK); horseradish peroxidase-conjugated
goat anti-mouse IgG(H+L) [F(ab’)2] from Thermo Fisher
Scientific (Waltham, MA, USA); and Alexa Fluor 594-
conjugated phalloidin and Alexa Fluor-labeled antibody
reagents were from Invitrogen.
Preparation of MDMs and infection with HIV-1BaL
MDMs, prepared from peripheral blood mononuclear
cells isolated from buffy coats from healthy blood donors
(National Blood Service, Essex, UK), as described previ-
ously [11], were cultured in complete medium (Roswell
Park Memorial Institute 1640, 100 U/ml penicillin, 0.1
mg/ml streptomycin, and 10% human AB serum) and
differentiated with 10 ng/ml of macrophage colony-
stimulating factor (R&D Systems, Abingdon, UK) for 2
days. Unless otherwise specified, the MDMs were used
after 14 days in culture. Stocks of HIV-1BaL were prepared
as described [11,34]. Where indicated, 7-day-old MDMs
were infected with HIV-1BaL (2 FFU/cell) by spinoculation
at 2,500 rpm for 2 hours at room temperature, and
cultured for a further 7 days.
Labeling of plasma membrane with lipid dyes
MDMs were washed in ice-cold PBS and incubated with
5 μg/ml FM 4-64FX (Invitrogen) in PBS for 30 minutes
on ice, washed in ice-cold PBS and fixed in 4% parafor-
maldehyde (PFA)/2% glutaraldehyde (TAAB Laboratories,
Aldermaston, UK). Alternatively, MDMs were washed in
PBS and treated with serum-free MDMs were washed in
PBS and treated with serum-free RPMI (Roswell Park Me-
morial Institute) 1640 containing 2.5 μg/ml CellMask
Plasma Membrane Stain (Invitrogen) for 5 minutes at
37°C or for 30 minutes at 4°C, washed in PBS and fixed
in 4% PFA.
Immunofluorescence
MDMs were fixed in 4% PFA, quenched with 50 mM
NH4Cl and permeabilized with 0.1% Triton X-100 in
PBS. After blocking in PBS with 1% BSA, MDMs were
labeled for 1 hour with primary antibodies diluted in
PBS with 1% BSA, washed, and labeled again with Alexa
Fluor-488 or 594-conjugated secondary antibodies for
1 hour. For actin staining, Alexa Fluor 594-conjugated
phalloidin was added together with the secondary anti-
body. Samples were washed in PBS with 1% BSA,
mounted in Moviol and analyzed by confocal microscopy.Confocal images were acquired with a Leica SPE confocal
microscope, 63× oil objective (NA 1.3) and Leica LAS
Software, and processed using Adobe Photoshop, ImageJ
and Fiji.
Immunostaining for PI(4,5)P2
In one protocol, MDMs were fixed for 15 minutes in 4%
PFA with 2% glutaraldehyde, cooled on ice for 2 minutes
and processed at 4°C. Cells were permeabilized for 45
minutes in 0.5% saponin, 5% normal goat serum (NGS),
50 mM NH4Cl in Buffer A (20 mM PIPES-NaOH, 137
mM NaCl, 2.7 mM KCl, pH 6.8) and incubated overnight
with antibody 2C11 (16 μg/ml, diluted in 0.5% saponin, 5%
NGS, 50 mM NH4Cl in Buffer A), washed in buffer A, and
stained with Alexa Fluor 488-labeled goat anti-mouse
IgM for 1 hour. Cells were washed in buffer A and fixed
in ice-cold 2% PFA for 15 minutes before mounting and
imaging.
In a second staining protocol, MDMs were fixed in 4%
PFA for 15 minutes at room temperature, cooled on ice
for 2 minutes and permeabilized in 0.2% Triton X-100, 5%
NGS in PBS for 45 minutes at 4°C. Cells were incubated
with 2C11 (diluted in 0.2% Triton X-100, 5% NGS in PBS)
overnight at 4°C, washed in PBS and stained with a second
antibody as above.
Plasmids and nucleofection
The PH domain of phospholipase Cδ cloned into pEGFP-
N1 (PH-GFP) was obtained from S. Cockroft (University
College London, UK) and the 2xFYVE domain cloned into
pEGFP-N1 from H. Stenmark (The Norwegian Radium
Hospital, Oslo, Norway). LifeAct-Ruby was obtained from
D. Cutler (Medical Research Council Laboratory for
Molecular Cell Biology, University College London, London,
UK). Codon-optimized Gag-GFP cloned into pEGFP-N1
was from W. Sundquist (University of Utah School of
Medicine, Salt Lake City, UT, USA). MDMs were nucleo-
fected with 5 μg of plasmid DNA using the macrophage
nucleofection kit (Amaxa Biosystems, Cologne, Germany)
according to the manufacturer’s instructions, seeded
into four-well Lab-Tek Chambered Coverglass units
(Thermo Fisher Scientific) and incubated at 37°C for 24
hours.
Live cell microscopy
MDMs nucleofected as above were imaged with an
UltraVIEW Vox spinning disc confocal system (PerkinElmer,
Cambridge, UK) fitted on a Nikon ECLIPSE Ti microscope
equipped with a temperature and CO2-controllable environ-
ment chamber. All images were taken with a Nikon 60×
NA 1.2 oil objective. Volocity 5.3.2 (Perkin Elmer) was
used for image acquisition and figures were constructed
using Volocity, Adobe Photoshop, ImageJ and Fiji software.
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FRAP measurements were carried out at 37°C using an
UltraVIEW Vox spinning disc microscope with a Nikon
100× NA 1.4 oil objective. After acquiring the base level
of fluorescence for 2 seconds, the region of interest (IPMC
in MDMs) was photobleached using a 20 millisecond laser
pulse (488 nm laser power at 50% intensity), and fluores-
cence recovery was monitored for 20 seconds by collecting
frames at maximum speed. For FLIP analysis, a region of
interest was bleached 10 times, consecutively, using the
488 nm laser at 50% intensity and the UltraVIEW PK
device. After each bleaching pulse, fluorescence recovery
was monitored in the bleached region and at other areas
of interest over 10 seconds. Data were analyzed and the
images processed as above.Electron microscopy
HIV-infected MDMs were fixed and embedded in Epon
or prepared for cryosectioning and immunolabeling as
described previously [11,14]. Ultrathin sections were
inspected with a Tecnai G2 Spirit transmission EM
(FEI, Eindhoven, The Netherlands) and digital images
recorded with a Morada 11 MegaPixel TEM camera
(Olympus Soft Imaging Solutions, Münster, Germany)
and AnalySIS software. Images were adjusted for bright-
ness and contrast, and figures were assembled with Adobe
Photoshop.Virus release assay and western blot analysis
HIV-infected MDMs were washed twice with PBS and
incubated for 2 hours in medium containing either 2
μM latrunculin A (Invitrogen), 5 μM cytochalasin D
(Invitrogen), or 1 μM cytochalasin E (MP Biomedicals,
Solon, OH, USA) or carrier (DMSO). HEK293T cells
were transfected with the HIV-1 molecular clone NL4.3-
R3A [35] and incubated for 48 hours at 37°C. The cells
were treated with 2 μM latrunculin A or DMSO for 2 hours
and virus-containing media were collected. Cell debris was
removed by centrifugation (2,000 rpm, 5 minutes) and the
viruses concentrated by centrifugation (47,000 rpm, 2
hours) through a 20% sucrose cushion. Cells and virus
pellets were lysed in Laemmli SDS sample buffer at 96°C
for 10 minutes and the proteins separated on 12% poly-
acrylamide gels. Subsequently, the proteins were transferred
onto polyvinylidene difluoride membranes (Millipore,
Billerica, MA, USA); the membranes were quenched, and
specific proteins detected using antibodies to p24/p55
or p17 and horseradish peroxidase-conjugated goat anti-
mouse secondary antibodies. Labeled protein bands were
detected using SuperSignal West Dura Substrate (Thermo
Fisher Scientific) and band intensities were recorded and
quantified using a LAS4000 CCD camera and ImageQuant
software (GE Healthcare, Buckinghamshire, UK).Additional files
Additional file 1: Movie 1. 3D reconstruction of an uninfected MDM
labeled with FM 4-64FX. Uninfected MDMs were labeled with 5 μg/ml
FM 4-64FX, fixed and analyzed by confocal microscopy. Fiji software was
used to assemble a 3D reconstruction from 131 optical z-slices (step size
of 0.04 μm). Cell as shown in Figure 1A-C.
Additional file 2: Figure S1. Cell-to-cell variability in the size and
morphology of the IPMCs. (A) MDMs were nucleofected to express Gag-GFP
and stained with FM 4-64FX 24 hours later. Confocal sections show
co-localization of Gag-GFP and the FM 4–64 dye in the IPMC. (B) MDMs
were labeled with the membrane-impermeable CellMask for 5 minutes at
37°C (or 30 minutes at 4°C; bottom row in panel B) and fixed. Confocal
sections show labeled cell surface and IPMCs in uninfected and HIV-infected
MDMs from the same donor. (C) MDMs were nucleofected with PH-GFP.
Confocal sections show labeled cell surface and IPMCs in uninfected and
HIV-infected MDMs from the same donor. Infected MDMs were detected by
staining for the HIV matrix protein p17 (bottom panels). All scale bars: 10 μm.
Additional file 3: Movie 2. 3D reconstruction of an uninfected MDM
labeled with CellMask. Uninfected MDMs were labeled with CellMask for
5 minutes at 37°C. Confocal sections were recorded using an UltraVIEW
Vox spinning disc confocal system (PerkinElmer, Cambridge, UK). Fiji
software was used to build this 3D reconstruction assembled from 165
optical z-slices (step size of 0.1 μm). Cell as shown in Figure 1D-F.
Additional file 4: Movie 3. 3D reconstruction of an uninfected MDM
expressing PH-GFP. Uninfected MDMs were nucleofected to express PH-
GFP for 24 hours, fixed and imaged by confocal microscopy. Fiji software
was used to assemble a 3D reconstruction from 230 optical z-slices (step
size of 0.04 μm). Cell as shown in Figure 1I-K.
Additional file 5: Figure S2. Immunostaining for PI(4,5)P2 in MDMs.
MDMs were either (A) fixed with 4% paraformaldehyde/2%
glutaraldehyde and permeabilized with 0.5% saponin or (B) fixed with 4%
paraformaldehyde and permeabilized in 0.2% Triton X-100. Cells were
labeled with a mouse monoclonal anti-PI(4,5)P2 antibody 2C11 and
co-stained for CD81. Scale bars: 10 μm.
Additional file 6: Movie 4. Live cell imaging of an uninfected MDM
nucleofected with PH-GFP. MDMs were nucleofected with PH-GFP and
imaged after 24 hours using an UltraVIEW Vox spinning disc confocal
system fitted on a Nikon ECLIPSE Ti microscope equipped with a
temperature and CO2-controllable environment chamber. The movie was
assembled from images taken every 10 seconds. Cell as shown in Figure 3A.
Additional file 7: Movie 5. Live cell imaging of an uninfected MDM
expressing PH-GFP. MDMs were nucleofected to express PH-GFP and
imaged after 24 hours using an UltraVIEW Vox spinning disc confocal
system fitted on a Nikon ECLIPSE Ti microscope equipped with a
temperature and CO2-controllable environment chamber. The movie was
assembled from images taken every 10 seconds. Cell as shown in Figure 3B.
Additional file 8: Figure S3. Latrunculin A induces the translocation of
actin into nuclei. MDMs were treated with 2 μM latrunculin A or DMSO
(control) for 2 hours. Cells were stained with Alexa Fluor 594-conjugated
phalloidin to label actin and 4′,6-diamidino-2-phenylindole to label nuclei.
The images show single optical sections acquired with a Leica SPE
confocal microscope. Scale bars: 10 μm.
Additional file 9: Figure S4. Latrunculin A, cytochalasin E or cytochalasin
D alter IPMC morphology and enhance HIV-1 release from MDMs.
HIV-infected MDMs were treated with 2 μM latrunculin A (Lat), 1 μM
cytochalasin E (CCE), 5 μM cytochalasin D (CCD) or DMSO (control) for 2
hours. (A) Cells were stained with an anti-p17 antibody that only recognizes
mature virus particles and Alexa Fluor 594-conjugated phalloidin to label
actin. The images show single optical sections acquired with a Leica SPE
confocal microscope. The cells marked by white squares are enlarged in the
bottom row. Scale bars: 10 μm. (B) Single optical sections showing
examples of compact, dispersed or both (mixed) compartments. Cells were
stained with antibodies against CD81 and p17. (C) MDMs were analyzed
according to the morphology of the IPMCs. Ten single optical sections
through the cells were acquired, inspected for the presence of IPMCs, and
cells containing either compact or dispersed IPMCs or both (mixed) were
counted. (D) The amount of virus released during treatment of MDMs with
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(AIDS and Cancer Virus Program NCI-Frederick, MD, USA). Results are shown
relative to the control untreated MDMs (DMSO).
Additional file 10: Figure S5. HIV particles still assemble in IPMCs after
treatment with latrunculin A. HIV-infected MDMs were treated with DMSO or
2 μM Latrunculin A for 2 hours and processed for cryosectioning. Ultrathin
cryosections from (A, B) infected control or (C, D, E) latrunculin A-treated
macrophages were immunolabeled with anti-p24 antibodies, a rabbit anti-
mouse bridging antibody and protein A-gold (5 nm in A, B and D, or 10 nm
in C and E). EM analysis showed that HIV particles accumulated in complex
IPMCs in both control and latrunculin A-treated cells. Arrows in B and D
show representative immature virus particles and budding profiles,
indicating virus assembly within IPMCs. Arrowheads in E mark an example of
the electron-dense coats containing β2-integrins and focal adhesion
proteins [14]. Images were taken on an FEI Tecnai G2 Spirit transmission EM
with a Morada 11 MegaPixel TEM camera and AnalySIS software. Scale bars:
1 μm in A and C, and 200 nm in B, D, E.
Additional file 11: Movie 6. 3D reconstruction of an infected MDM
labeled with CellMask and treated with latrunculin A. MDMs infected for
7 days with HIV-1BaL were treated with DMSO (control) or latrunculin A
for 2 hours and labeled with CellMask. Fiji software was used to build a
3D reconstruction of an IPMC from 200 optical z-slices (step size of 0.04
μm). The 3D reconstructions were cut out from whole cells to display the
individual compartments. The control cell is shown on the left, and the
reconstruction from a latrunculin-treated cell on the right. Note multiple
connections to the cell surface.
Additional file 12: Figure S6. Effect of latrunculin A on PH-GFP
expressing MDMs. MDMs were nucleofected to express PH-GFP for 24
hours and then treated with DMSO (control) or latrunculin A for 2 hours.
(A) The images show single optical sections acquired with a Leica SPE
confocal microscope. (B) Both 3D reconstructions of IPMCs were built
from 142 optical z-slices (step size of 0.04 μm). The 3D reconstructions
were cut out from whole cells to display the individual compartments.
Scale bars: 10 μm.
Additional file 13: Movie 7. 3D reconstruction of uninfected MDMs
expressing PH-GFP and treated with latrunculin A. MDMs were nucleofected
to express PH-GFP for 24 hours and then treated with DMSO (control) or
latrunculin A for 2 hours. Fiji software was used to build 3D reconstructions of
IPMCs from 142 optical z-slices (step size of 0.04 μm). The 3D reconstructions
were cut out from the whole cell to better display the individual
compartments. The control cell is shown on the left, and the reconstruction
from a latrunculin-treated cell on the right. Note multiple connections to the
cell surface. Cells as shown in Figure S6 in Additional file 12.
Additional file 14: Movie 8. Live cell imaging of MDMs expressing
Gag-GFP. Cells were imaged with the UltraVIEW Vox spinning disc
confocal system. Images were recorded at 6 frames/minute. Cell as
shown in Figure 6D.
Additional file 15: Movie 9. Live cell imaging of Gag-GFP in an IPMC.
MDMs were nucleofected to express Gag-GFP and imaged with the
UltraVIEW Vox spinning disc confocal system. Images were recorded at 6
frames/minute. Cell as shown in Figure 6E.
Additional file 16: Movie 10. Live cell imaging of MDMs expressing
Gag-GFP and LifeAct-Ruby: Effect of latrunculin treatment. MDMs were
nucleofected to express Gag-GFP and LifeAct-Ruby for 24 hours then
treated with 2 μM latrunculin A and imaged for 1.5 hours with the
UltraVIEW Vox spinning disc confocal system. Images were recorded at 6
frames/minute. Cell as shown in Figure 6F.
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